Product image of Pantoprazol Ametas (Pantoprazole Sodium Sesquihydrate) supplied by GNH India

Pantoprazol Ametas

Active Ingredient:
Pantoprazole Sodium Sesquihydrate
Origin:
EU

Pantoprazol Ametas (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Pantoprazol Ametas, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is employed in the management of acid‑related gastrointestinal disorders in adults.
GNH India supplies Pantoprazol Ametas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ametas Medical Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pantoprazol Ametas, a proton pump inhibitor, is indicated for conditions characterized by excessive gastric acid production.

  • Gastroesophageal reflux disease (GERD): alleviates reflux symptoms and promotes healing of esophageal irritation.
  • Erosive esophagitis: reduces acid exposure to allow mucosal recovery.
  • Zollinger‑Ellison syndrome: controls hypersecretion of gastric acid caused by gastrin‑producing tumors.
  • NSAID‑induced ulcer prophylaxis: lowers the risk of ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs.

How It Works

  • Pantoprazole sodium sesquihydrate selectively and irreversibly inhibits the H+/K+ ATPase enzyme (gastric proton pump) located on the secretory surface of parietal cells. By blocking this final step of acid secretion, it markedly reduces both basal and stimulated gastric acid output, leading to an increased gastric pH and facilitating mucosal healing.

Side Effects

Pantoprazol Ametas is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Headache: mild to moderate intensity, often transient.
  • Diarrhea: loose stools that may resolve with continued therapy.
  • Nausea: feeling of queasiness, usually mild.
  • Abdominal pain: discomfort in the stomach region.
  • Flatulence: increased intestinal gas.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis): swelling, rash, difficulty breathing.
  • Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
  • Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat.
  • Elevated liver enzymes: signs of hepatic stress.
  • Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.
  • Interstitial nephritis: kidney inflammation presenting with decreased urine output.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Assess renal function: adjust use in patients with severe impairment.
  • Monitor magnesium levels: especially during prolonged treatment.
  • Review concomitant medications: avoid known contraindicated drugs such as atazanavir.
  • Use caution in hepatic disease: dose may need modification.
  • Store at ambient temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Pantoprazol Ametas may interact with several medicines; awareness of the interaction level guides management.

Major Interactions (Avoid)

  • Clopidogrel: reduced antiplatelet effectiveness.
  • Atazanavir: decreased absorption of atazanavir, compromising HIV therapy.
  • High‑dose methotrexate: increased toxicity risk.

Moderate Interactions (Monitor Closely)

  • Warfarin: potential increase in INR, requiring closer monitoring.
  • Diazepam: possible elevation of plasma concentrations.
  • Digoxin: may raise serum levels, necessitating dose adjustment.

Frequently Asked Questions

Pantoprazol Ametas contains pantoprazole, a proton pump inhibitor prescribed to treat gastroesophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome, and to prevent ulcers in patients taking NSAIDs.

Pantoprazole blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, in the parietal cells of the stomach. This inhibition stops the final step of acid production, leading to a sustained increase in gastric pH and reduced acid-related damage.

The specific dose and treatment duration are determined by the prescribing healthcare professional based on the patient’s condition, severity, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for pantoprazole in pregnancy and lactation are limited. The prescriber will weigh potential benefits against possible risks before recommending use in pregnant or nursing women. Patients should discuss any concerns with their healthcare provider.

To request Pantoprazol Ametas, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Pantoprazol Ametas belongs to the proton pump inhibitor class, offering more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, pantoprazole has a similar efficacy profile but may have a lower potential for drug‑drug interactions involving CYP2C19 metabolism.

Pantoprazol Ametas should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Pantoprazol Ametas is taken orally, usually as a tablet or capsule, with water. It can be taken with or without food, but patients should follow the prescriber’s guidance on timing relative to meals for optimal effect.

Serious risks, though uncommon, include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, low magnesium levels, and rare skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms such as rash, swelling, persistent diarrhea, or muscle cramps.

Pantoprazol Ametas should be avoided in individuals with known hypersensitivity to pantoprazole or other proton pump inhibitors. Caution is also advised for patients with severe liver disease, those taking contraindicated medications, and anyone for whom acid suppression is not indicated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pantoprazole Sodium Sesquihydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT